Edgardo Kaplinsky

Director Médico de @etalpharma Cardiólogo del Hospital de Badalona

[Edgardo Kaplinsky @EdgarKap]

@GunnerPuls Veron

[Edgardo Kaplinsky @EdgarKap]

@JPinilla_MD @barba001barbage Muchas gracias a ti

[Edgardo Kaplinsky @EdgarKap]

Please, join us

[Edgardo Kaplinsky @EdgarKap]

Dear friends, please collaborate

[Edgardo Kaplinsky @EdgarKap]

Dear colleagues, I invite you to participate in our special series on heart failure, which we aim to cover in a comprehensive and inclusive manner. Thank you very much.

[Edgardo Kaplinsky @EdgarKap]

Dear colleagues, please collaborate with our special issue: Heart
Failure: Personalized Diagnosis, Treatment and Management https://t.co/kpr4ebFTAN

[Edgardo Kaplinsky @EdgarKap]

🫀 AI model TRisk predicts 36-month mortality in HF patients with C-index 0.845, outperforming MAGGIC-EHR (0.728) — from a multi-cohort study.
📖 AI-enhanced risk stratification may improve HF management.
🔗 https://t.co/5mPGrwbMPB
#Cardiology #HeartFailure #AIinMedicin

[Edgardo Kaplinsky @EdgarKap]

🫀 Coenzyme Q10 supplementation (300 mg/day) in chronic HF patients reduces mortality and hospitalizations — Q-SYMBIO trial.
📖 Adjunctive CoQ10 therapy may improve outcomes in HF.
🔗 https://t.co/pfiWnpS5rQ
#Cardiology #HeartFailure #CoQ1

[Edgardo Kaplinsky @EdgarKap]

🫀 AF ablation reduces pulmonary wedge pressure in HFpEF patients — from a randomized controlled trial (JACC, RCT).

📖 Ablation may improve hemodynamics in HFpEF with AF, suggesting a potential therapeutic role beyond rhythm control.

🔗 https://t.co/LZ94oAuNLf

📊

#HFpEF #AtrialFibrillation #Cardiology #MedTwitter

[Edgardo Kaplinsky @EdgarKap]

🫀 First-in-human implantable IVC sensor safely monitors volume status in HF patients — from a feasibility study (JACC, device trial).

📖 Real-time hemodynamic monitoring via IVC sensors could enable proactive HF management and reduce hospitalizations.

🔗 https://t.co/YrqRbq4ofx

📊

#HeartFailure #DigitalHealth #MedTwitter

[Edgardo Kaplinsky @EdgarKap]

🫀 Finerenone shows consistent benefits across kidney risk strata in HF patients — from a pooled analysis of FIDELIO-DKD & FIGARO-DKD trials (JACC, post hoc analysis).

📖 Suggests finerenone's efficacy is maintained regardless of baseline kidney function, supporting its use across a broad HF population.

🔗 https://t.co/JvCmi1twyl

📊

#HeartFailure #CKD #Finerenone #MedTwitter

[Edgardo Kaplinsky @EdgarKap]

🚨 BIG News in Cardiology! 🚨 The latest JACC reveals vutrisiran significantly improves survival & reduces CV events in #ATTRCM cardiomyopathy. A game-changer for patients! 💪

Check out the pivotal HELIOS-B trial: 👉 https://t.co/t07VH0TB18
#Cardiology #HeartHealth #Amyloidosis #MedicalBreakthrough

[Edgardo Kaplinsky @EdgarKap]

@RabinoGarmon España

[Edgardo Kaplinsky @EdgarKap]

@RabinoGarmon Claro que si, desde Españs

[Edgardo Kaplinsky @EdgarKap]

@FedeAlonss 12 111

[Edgardo Kaplinsky @EdgarKap]

@FedeAlonss 431

[Edgardo Kaplinsky @EdgarKap]

@FedeAlonss [phone]+34 650 94 19 33

[Edgardo Kaplinsky @EdgarKap]

@FedeAlonss http+34 650 94 19 33s://theobjective.com/sanidad/2024-05-22/clinic-barcelona-implanta-catalan-lengua-propia-hospital/?amp+34 650 94 19 33

[Edgardo Kaplinsky @EdgarKap]

@FedeAlonss [phone]

[Edgardo Kaplinsky @EdgarKap]

@FedeAlonss Y